Chih-Kwang Sung, MD
Otolaryngology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sung’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A112816 · Current
Licensed to practise in California · since 2010 · expires 2028-06-30 · State University of New York Health Science Center at Brooklyn.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$93,457
Medicare paid this office $93,457 for 336 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Exam to assess movement of vocal cord flaps using an endoscope | 86 | $9,769 | $107 |
| Exam to assess movement of vocal cord flaps using an endoscope | 87 | $9,488 | $101 |
| Diagnostic exam of voice box using a flexible endoscope | 94 | $6,844 | $58 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 24 | $6,619 | $221 |
| Diagnostic exam of voice box using a flexible endoscope | 62 | $4,352 | $64 |
See all 20 services
| Exam to assess movement of vocal cord flaps using an endoscope | 86 | $9,769 | $107 |
| Exam to assess movement of vocal cord flaps using an endoscope | 87 | $9,488 | $101 |
| Diagnostic exam of voice box using a flexible endoscope | 94 | $6,844 | $58 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 24 | $6,619 | $221 |
| Diagnostic exam of voice box using a flexible endoscope | 62 | $4,352 | $64 |
| New patient visit (30+ min) | 57 | $3,865 | $68 |
| Removal or destruction of growth of side of voice box using an endoscope | 12 | $2,759 | $184 |
| Injection of chemical for paralysis of nerve muscles on side of voice box | 13 | $2,734 | $124 |
| Return visit (30+ min) | 30 | $2,633 | $82 |
| New patient visit (30+ min) | 32 | $2,294 | $72 |
| Injection of substance to augment voice box using an endoscope | 14 | $2,052 | $147 |
| Injection into vocal cords using an endoscope with operating microscope or telescope | 13 | $1,961 | $140 |
| Short return visit (20+ min) | 30 | $1,961 | $54 |
| Return visit (30+ min) | 20 | $1,815 | $91 |
| Balloon dilation of esophagus using a rigid endoscope, less than 3.0 cm | 11 | $1,757 | $135 |
| Short return visit (20+ min) | 22 | $1,591 | $64 |
| New patient visit (45+ min) | 12 | $1,426 | $119 |
| New patient visit (45+ min) | 11 | $1,080 | $98 |
| Short return visit | 25 | $823 | $32 |
| Short return visit | 25 | $820 | $32 |
Procedures Medicare counted
| Upper gastrointestinal (GI) endoscopy for acid reflux | 16 | More than 47% of doctors who do this |
Who their Medicare patients are
336 Original Medicare patients in 2024. Average age 74 · Under 65 8% · 85 and older 11% · Women 47% · Also on Medicaid 21% · Health risk score 1.68. Sicker patients than 9 in 10 peers; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 67% · Coronary heart disease 31% · Diabetes 30% · Cancer 24% · COPD 23% · Chronic kidney disease 21% · Atrial fibrillation 21% · Depression 20% · Heart failure 19% · Stroke 11% · Dementia 5%.
The office billed $891,165, Medicare allowed $123,016 and paid $93,457; for 908 services of 43 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 336 | 908 | 74 | 1.68 | $891,165 | $93,457 |
| 2023 | 293 | 797 | 74 | 1.49 | $540,565 | $82,745 |
| 2022 | 329 | 860 | 74 | 1.62 | $580,774 | $92,982 |
| 2021 | 263 | 758 | 73 | 1.53 | $448,188 | $77,070 |
| 2020 | 225 | 696 | 73 | 1.63 | $443,315 | $67,465 |
| 2019 | 267 | 836 | 73 | 1.64 | $387,583 | $76,436 |
| 2018 | 284 | 1,009 | 72 | 1.96 | $412,373 | $89,523 |
| 2017 | 275 | 896 | 71 | 1.85 | $445,931 | $73,925 |
| 2016 | 340 | 1,044 | 71 | 1.78 | $577,640 | $104,087 |
| 2015 | 237 | 803 | 72 | 1.60 | $420,469 | $80,484 |
| 2014 | 169 | 594 | 71 | 1.44 | $329,646 | $57,329 |
| 2013 | 127 | 335 | 70 | 1.54 | $161,890 | $26,623 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Exam to assess movement of vocal cord flaps using an endoscope | 126 | $15,590 | $103 |
| Diagnostic exam of voice box using a flexible endoscope | 129 | $11,491 | $60 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 20 | $5,461 | $237 |
| Injection of chemical for paralysis of nerve muscles on side of voice box | 17 | $5,316 | $144 |
| Short return visit (20+ min) | 78 | $5,190 | $58 |
| New patient visit (30+ min) | 64 | $4,704 | $74 |
| Injection of substance to augment voice box using an endoscope | 13 | $2,242 | $160 |
| Return visit (30+ min) | 26 | $2,191 | $81 |
| Short return visit | 49 | $1,601 | $31 |
| New patient visit (15+ min) | 15 | $666 | $44 |
2022: 13 services
| Exam to assess movement of vocal cord flaps using an endoscope | 145 | $16,788 | $102 |
| Diagnostic exam of voice box using a flexible endoscope | 134 | $10,528 | $58 |
| Return visit (30+ min) | 70 | $5,987 | $82 |
| New patient visit (30+ min) | 75 | $5,319 | $71 |
| New patient visit (45+ min) | 40 | $4,821 | $121 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 18 | $4,339 | $241 |
| Short return visit (20+ min) | 66 | $4,211 | $58 |
| Injection of chemical for paralysis of nerve muscles on side of voice box | 15 | $4,178 | $127 |
| Injection of substance to augment voice box using an endoscope | 19 | $3,265 | $148 |
| Long return visit (40+ min) | 19 | $2,335 | $123 |
| Removal or destruction of growth of side of voice box using an endoscope | 11 | $1,889 | $157 |
| Exam of windpipe and lung airways through permanent windpipe opening using an endoscope | 11 | $1,230 | $95 |
| Short return visit | 23 | $639 | $26 |
2021: 11 services
| Exam to assess movement of vocal cord flaps using an endoscope | 104 | $11,670 | $101 |
| Diagnostic exam of voice box using a flexible endoscope | 126 | $9,830 | $57 |
| Return visit (30+ min) | 78 | $7,527 | $90 |
| Short return visit (20+ min) | 93 | $6,307 | $56 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 15 | $3,708 | $232 |
| New patient visit (30+ min) | 46 | $3,412 | $74 |
| Injection of chemical for paralysis of nerve muscles on side of voice box | 12 | $3,171 | $138 |
| Injection of substance to augment voice box using an endoscope | 17 | $2,707 | $159 |
| Long return visit (40+ min) | 14 | $1,777 | $127 |
| New patient visit (45+ min) | 12 | $1,449 | $121 |
| Short return visit | 31 | $832 | $24 |
2020: 10 services
| Exam to assess movement of vocal cord flaps using an endoscope | 87 | $10,294 | $105 |
| Diagnostic exam of voice box using a flexible endoscope | 83 | $7,322 | $60 |
| Short return visit (20+ min) | 101 | $6,585 | $44 |
| Return visit (30+ min) | 47 | $3,763 | $74 |
| New patient visit (30+ min) | 55 | $3,730 | $68 |
| Injection of substance to augment voice box using an endoscope | 20 | $2,929 | $139 |
| Injection of chemical for paralysis of nerve muscles on side of voice box | 11 | $2,853 | $130 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 12 | $2,485 | $191 |
| Removal or destruction of growth of side of voice box using an endoscope | 11 | $2,168 | $181 |
| Short return visit | 34 | $906 | $22 |
2019: 8 services
| Exam to assess movement of vocal cord flaps using an endoscope | 137 | $15,286 | $101 |
| Short return visit (20+ min) | 137 | $9,277 | $44 |
| Diagnostic exam of voice box using a flexible endoscope | 102 | $7,794 | $58 |
| New patient visit (30+ min) | 76 | $5,061 | $67 |
| Injection of substance to augment voice box using an endoscope | 16 | $3,499 | $152 |
| Return visit (30+ min) | 49 | $3,475 | $68 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 13 | $3,350 | $223 |
| Short return visit | 24 | $624 | $20 |
2018: 9 services
| Exam to assess movement of vocal cord flaps using an endoscope | 142 | $17,741 | $104 |
| Diagnostic exam of voice box using a flexible endoscope | 142 | $13,449 | $58 |
| Short return visit (20+ min) | 159 | $11,982 | $44 |
| Repair of side of voice box by moving vocal cord to middle | 12 | $11,685 | $974 |
| New patient visit (30+ min) | 86 | $5,504 | $64 |
| Return visit (30+ min) | 59 | $4,698 | $70 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 14 | $3,592 | $211 |
| Injection of substance to augment voice box using an endoscope | 14 | $2,080 | $130 |
| Short return visit | 27 | $683 | $22 |
2017: 8 services
| Exam to assess movement of vocal cord flaps using an endoscope | 136 | $14,923 | $97 |
| Diagnostic exam of voice box using a flexible endoscope | 128 | $10,930 | $56 |
| Short return visit (20+ min) | 135 | $8,721 | $42 |
| New patient visit (30+ min) | 86 | $5,531 | $64 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 14 | $4,526 | $238 |
| Return visit (30+ min) | 57 | $4,050 | $70 |
| Injection of substance to augment voice box using an endoscope | 22 | $3,128 | $125 |
| Short return visit | 33 | $795 | $20 |
2016: 8 services
| Exam to assess movement of vocal cord flaps using an endoscope | 162 | $22,432 | $124 |
| Diagnostic exam of voice box using a flexible endoscope | 166 | $16,219 | $68 |
| Short return visit (20+ min) | 155 | $9,906 | $44 |
| New patient visit (30+ min) | 144 | $9,705 | $67 |
| Injection into vocal cords using an endoscope with operating microscope or telescope | 26 | $8,414 | $210 |
| Removal of growth of tongue and/or stripping of vocal cord using an endoscope with operating microscope or telescope | 19 | $6,134 | $236 |
| Return visit (30+ min) | 62 | $4,483 | $70 |
| Short return visit | 41 | $1,004 | $22 |
2015: 7 services
| Exam to assess movement of vocal cord flaps using an endoscope | 94 | $14,871 | $126 |
| Diagnostic exam of voice box using a flexible endoscope | 136 | $13,419 | $68 |
| Short return visit (20+ min) | 139 | $9,243 | $44 |
| Injection into vocal cords using an endoscope with operating microscope or telescope | 21 | $8,138 | $220 |
| New patient visit (30+ min) | 86 | $5,711 | $66 |
| Return visit (30+ min) | 33 | $2,341 | $69 |
| Short return visit | 21 | $637 | $22 |
2014: 6 services
| Exam to assess movement of vocal cord flaps using an endoscope | 78 | $13,337 | $120 |
| Diagnostic exam of voice box using a flexible endoscope | 79 | $7,823 | $66 |
| Short return visit (20+ min) | 102 | $7,182 | $43 |
| Injection into vocal cords using an endoscope with operating microscope or telescope | 16 | $4,138 | $207 |
| New patient visit (30+ min) | 59 | $3,781 | $64 |
| Return visit (30+ min) | 22 | $1,477 | $64 |
2013: 5 services
| Diagnostic exam of voice box using a flexible endoscope | 70 | $5,409 | $66 |
| Short return visit (20+ min) | 70 | $4,154 | $41 |
| New patient visit (30+ min) | 37 | $2,315 | $63 |
| Return visit (30+ min) | 20 | $1,339 | $64 |
| Short return visit | 16 | $347 | $18 |
Medicaid work
$4,321 in 2024
Medicaid paid $4,321 for 115 billed services this clinician did in 2024, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Diagnostic flexible fiberoptic laryngoscopy | 77 | $2,891 |
| Rigid fiberoptic laryngoscopy with stroboscopy | 26 | $1,039 |
| Service | 12 | $392 |
| 2024 | 115 | 3 | 20 | $4,321 |
| 2023 | 53 | 1 | 16 | $2,090 |
| 2022 | 44 | 1 | 17 | $1,554 |
| 2021 | 32 | 1 | 17 | $1,024 |
| 2018 | 28 | 1 | 15 | $1,149 |
See the largest Medicaid services in earlier years
2023
| Diagnostic flexible fiberoptic laryngoscopy | 53 | $2,090 |
2022
| Diagnostic flexible fiberoptic laryngoscopy | 44 | $1,554 |
2021
| Diagnostic flexible fiberoptic laryngoscopy | 32 | $1,024 |
2018
| Diagnostic flexible fiberoptic laryngoscopy | 28 | $1,149 |
Drugs they prescribed that Part D paid
$631
Pharmacies billed $631 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
42 generic and fewer than 11 brand-name prescriptions · $631 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Famotidine | 11 | $79 | $7 |
Year by year
| 2024 | 44 | 26 | None | None | $631 |
| 2023 | 68 | 31 | None | None | $2,445 |
| 2022 | 62 | 24 | 0% (0) | 0% | $1,842 |
| 2021 | 47 | 25 | None | None | $3,576 |
| 2020 | 44 | 17 | 0% (0) | None | $3,474 |
| 2019 | 70 | 27 | None | None | $3,328 |
| 2018 | 105 | 46 | None | None | $2,302 |
| 2017 | 167 | 63 | None | None | $3,402 |
| 2016 | 190 | 62 | None | 7% | $9,329 |
| 2015 | 159 | 52 | None | None | $6,392 |
| 2014 | 86 | 35 | None | None | $4,798 |
| 2013 | 98 | 36 | None | None | $4,715 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Omeprazole | 19 | $524 | $28 |
2021: 1 drug
| Omeprazole | 15 | $209 | $14 |
2019: 1 drug
| Ampicillin-Sulbactam | 19 | $1,654 | $87 |
2018: 3 drugs
| Ranitidine | 26 | $372 | $14 |
| Omeprazole | 23 | $326 | $14 |
| Fluticasone Propionate | 13 | $144 | $11 |
2017: 4 drugs
| Omeprazole | 37 | $828 | $22 |
| Ranitidine | 40 | $713 | $18 |
| Gabapentin | 17 | $285 | $17 |
| Nortriptyline | 11 | $226 | $21 |
2016: 4 drugs
| Ranitidine | 58 | $1,222 | $21 |
| Omeprazole | 35 | $1,097 | $31 |
| Gabapentin | 20 | $403 | $20 |
| Fluticasone Propionate | 11 | $136 | $12 |
2015: 2 drugs
| Ranitidine | 48 | $589 | $12 |
| Omeprazole | 42 | $578 | $14 |
2014: 2 drugs
| Omeprazole | 22 | $383 | $17 |
| Ranitidine | 15 | $158 | $11 |
2013: 3 drugs
| Omeprazole | 19 | $754 | $40 |
| Ranitidine | 30 | $365 | $12 |
| Fluticasone Propionate | 13 | $254 | $20 |
Money from drug and device companies
$155 in 2024
| 2024 | 1 | 1 | None | $155 |
| 2023 | 1 | 1 | None | $138 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Olympus America | Olympus | $155 | 1 payment
|
See the published payment
| Olympus America | Meals · 2024-10-25 | Olympus | $155 |
See earlier years (2023)
2023: $138
| KLS-Martin L.P. | None | $138 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1407019144
- Licence
- CA A112816, NY 239790California A112816: Current · expires 2028-06-30
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2008-07-02
- NPI last updated
- 2025-04-17
- NPI record certified
- 2025-04-17
This is when the NPI record was last certified, not a medical board exam.